Auxly Cannabis Group Temettü
Temettü kriter kontrolleri 0/6
Auxly Cannabis Group does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
-2.2%
Geri Alım Getirisi
Toplam Hissedar Getirisi | -2.2% |
Gelecekteki Temettü Verimi | n/a |
Temettü Büyümesi | n/a |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | n/a |
Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Investors Still Aren't Entirely Convinced By Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Despite 43% Price Jump
Nov 03Is Auxly Cannabis Group (TSE:XLY) A Risky Investment?
Oct 02Auxly Cannabis Group Inc.'s (TSE:XLY) Shares Leap 60% Yet They're Still Not Telling The Full Story
Aug 09Market Cool On Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Pushing Shares 40% Lower
Jun 19Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?
Apr 27A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb
Mar 21Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company
Feb 03Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper
Dec 19Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?
Oct 17Is Auxly Cannabis Group (TSE:XLY) Using Debt In A Risky Way?
Jul 14Auxly Cannabis Group Inc. (TSE:XLY) Could Be Riskier Than It Looks
Apr 17The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically
Aug 11Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?
Jul 21Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%
Aug 18Auxly Cannabis Group Inc. (TSE:XLY) Just Reported And Analysts Have Been Cutting Their Estimates
Apr 29Breakeven On The Horizon For Auxly Cannabis Group Inc. (CVE:XLY)
Mar 24A Look At Auxly Cannabis Group's (CVE:XLY) Share Price Returns
Jan 28Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if XLY's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if XLY's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
Auxly Cannabis Group Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (XLY) | n/a |
Pazarın Alt %25'i (CA) | 1.8% |
Pazarın En İyi %25'i (CA) | 6.1% |
Sektör Ortalaması (Pharmaceuticals) | 2.3% |
Analist tahmini (XLY) (3 yıla kadar) | n/a |
Önemli Temettü: Unable to evaluate XLY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate XLY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate XLY's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as XLY has not reported any payouts.